Recall events
/
Event 70118
Event summary
Timeline bucket December 26, 2014
Product types Drug
Classifications Class II and Class III
Statuses Terminated
Recalling firm wording Walgreens Infusion Services
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
36 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 36
Liposomal Amphotericin B 130 mg in dextrose bags
D-0340-2015
Recall number D-0340-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[6313]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 36
Amikacin various strength in normal saline bags
D-0341-2015
Recall number D-0341-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[6534]
FDA event record
· Exact recall-number query on openFDA
drug · product 3 of 36
Aztreonam 1 gram in normal saline
D-0342-2015
Recall number D-0342-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[7779]
FDA event record
· Exact recall-number query on openFDA
drug · product 4 of 36
Cefepime various strengths in normal saline
D-0343-2015
Recall number D-0343-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[9216]
FDA event record
· Exact recall-number query on openFDA
drug · product 5 of 36
Cefoxitin various strength in normal saline bags
D-0344-2015
Recall number D-0344-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[5996]
FDA event record
· Exact recall-number query on openFDA
drug · product 6 of 36
Ceftazidime various strength in normal saline bags
D-0345-2015
Recall number D-0345-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[8004]
FDA event record
· Exact recall-number query on openFDA
drug · product 7 of 36
Imipenem/ cilastatin various strength in normal saline bags
D-0346-2015
Recall number D-0346-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[6310]
FDA event record
· Exact recall-number query on openFDA
drug · product 8 of 36
Ertapenem various strength in normal saline bags
D-0347-2015
Recall number D-0347-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[8007]
FDA event record
· Exact recall-number query on openFDA
drug · product 9 of 36
Piperacillin/ tazobactam various strength in normal saline bags
D-0348-2015
Recall number D-0348-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[7758]
FDA event record
· Exact recall-number query on openFDA
drug · product 10 of 36
Vancomycin various strengths in normal saline bags
D-0349-2015
Recall number D-0349-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[8023]
FDA event record
· Exact recall-number query on openFDA
drug · product 11 of 36
Cefuroxime various strengths in normal saline bags
D-0350-2015
Recall number D-0350-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[6306]
FDA event record
· Exact recall-number query on openFDA
drug · product 12 of 36
Meropenem various strengths in normal saline bags
D-0351-2015
Recall number D-0351-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[8012]
FDA event record
· Exact recall-number query on openFDA
drug · product 13 of 36
Nafcillin various strengths in sterile water for injection bags
D-0352-2015
Recall number D-0352-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[6527]
FDA event record
· Exact recall-number query on openFDA
drug · product 14 of 36
Cefazolin various strengths in normal saline bags
D-0353-2015
Recall number D-0353-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[5999]
FDA event record
· Exact recall-number query on openFDA
drug · product 15 of 36
Tobramycin various strengths in normal saline bags
D-0354-2015
Recall number D-0354-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[6542]
FDA event record
· Exact recall-number query on openFDA
drug · product 16 of 36
Gentamicin various strength in normal saline bags
D-0355-2015
Recall number D-0355-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[7776]
FDA event record
· Exact recall-number query on openFDA
drug · product 17 of 36
Daptomycin various strengths in normal saline bags
D-0356-2015
Recall number D-0356-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[6308]
FDA event record
· Exact recall-number query on openFDA
drug · product 18 of 36
Ceftriaxone various strengths in normal saline
D-0357-2015
Recall number D-0357-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[8738]
FDA event record
· Exact recall-number query on openFDA
drug · product 19 of 36
Levofloxacin various strengths in normal saline
D-0358-2015
Recall number D-0358-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[9212]
FDA event record
· Exact recall-number query on openFDA
drug · product 20 of 36
Linezolid various strengths in dextrose
D-0359-2015
Recall number D-0359-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[6536]
FDA event record
· Exact recall-number query on openFDA
drug · product 21 of 36
Tigecycline various strengths in normal saline
D-0360-2015
Recall number D-0360-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[7771]
FDA event record
· Exact recall-number query on openFDA
drug · product 22 of 36
Acyclovir various strengths in normal saline
D-0361-2015
Recall number D-0361-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[7755]
FDA event record
· Exact recall-number query on openFDA
drug · product 23 of 36
Milrinone various strengths in dextrose
D-0362-2015
Recall number D-0362-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[6727]
FDA event record
· Exact recall-number query on openFDA
drug · product 24 of 36
Caspofungin various strengths in normal saline
D-0363-2015
Recall number D-0363-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[6530]
FDA event record
· Exact recall-number query on openFDA
drug · product 25 of 36
Dobutamine various strengths in dextrose
D-0364-2015
Recall number D-0364-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[7768]
FDA event record
· Exact recall-number query on openFDA
drug · product 26 of 36
Dopamine various strengths in dextrose
D-0365-2015
Recall number D-0365-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[7805]
FDA event record
· Exact recall-number query on openFDA
drug · product 27 of 36
Folic acid 1 mg/ 0.2 ml pre-drawn syringes
D-0366-2015
Recall number D-0366-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[7765]
FDA event record
· Exact recall-number query on openFDA
drug · product 28 of 36
Thiamine 100 mg/ ml vials
D-0367-2015
Recall number D-0367-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[7801]
FDA event record
· Exact recall-number query on openFDA
drug · product 29 of 36
Ranitidine various strengths in syringes
D-0368-2015
Recall number D-0368-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[8843]
FDA event record
· Exact recall-number query on openFDA
drug · product 30 of 36
Magnesium sulfate various strengths in sodium chloride
D-0369-2015
Recall number D-0369-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[7773]
FDA event record
· Exact recall-number query on openFDA
drug · product 31 of 36
Deferoxamine various strengths in normal saline
D-0370-2015
Recall number D-0370-2015
Initiated December 26, 2014
Classification Class III
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[8020]
FDA event record
· Exact recall-number query on openFDA
drug · product 32 of 36
Dehydrated alcohol vials
D-0371-2015
Recall number D-0371-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[6538]
FDA event record
· Exact recall-number query on openFDA
drug · product 33 of 36
Diphenhydramine 50 mg/ml vials
D-0372-2015
Recall number D-0372-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[8029]
FDA event record
· Exact recall-number query on openFDA
drug · product 34 of 36
Immune globulin g human various strengths
D-0373-2015
Recall number D-0373-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[8740]
FDA event record
· Exact recall-number query on openFDA
drug · product 35 of 36
L-cysteine various strengths
D-0374-2015
Recall number D-0374-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[8747]
FDA event record
· Exact recall-number query on openFDA
drug · product 36 of 36
Total parenteral nutrition various strengths
D-0375-2015
Recall number D-0375-2015
Initiated December 26, 2014
Classification Class II
Status Terminated
Quantity N/A
App-derived interpretation
Sterility assurance
reason.sterility_assurance · v1.0.0
Lack of sterility
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Lack of sterility assurance.
Code information All products within expiry.
Distribution pattern Texas, Florida, Virginia, Georgia, Louisiana, Mississippi
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[5991]
FDA event record
· Exact recall-number query on openFDA
